BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19436099)

  • 1. On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams.
    Andreo P
    Phys Med Biol; 2009 Jun; 54(11):N205-15. PubMed ID: 19436099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy.
    Lühr A; Hansen DC; Jäkel O; Sobolevsky N; Bassler N
    Phys Med Biol; 2011 Apr; 56(8):2515-33. PubMed ID: 21441652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluence correction factors and stopping power ratios for clinical ion beams.
    Lühr A; Hansen DC; Sobolevsky N; Palmans H; Rossomme S; Bassler N
    Acta Oncol; 2011 Aug; 50(6):797-805. PubMed ID: 21767177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical theory for the fluence, planar fluence, energy fluence, planar energy fluence and absorbed dose of primary particles and their fragments in broad therapeutic light ion beams.
    Kempe J; Brahme A
    Phys Med; 2010 Jan; 26(1):6-16. PubMed ID: 19345598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams.
    Sawakuchi GO; Titt U; Mirkovic D; Ciangaru G; Zhu XR; Sahoo N; Gillin MT; Mohan R
    Phys Med Biol; 2010 Feb; 55(3):711-21. PubMed ID: 20071752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
    Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
    Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo based water/medium stopping-power ratios for various ICRP and ICRU tissues.
    Fernández-Varea JM; Carrasco P; Panettieri V; Brualla L
    Phys Med Biol; 2007 Nov; 52(21):6475-83. PubMed ID: 17951856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assigning nonelastic nuclear interaction cross sections to Hounsfield units for Monte Carlo treatment planning of proton beams.
    Palmans H; Verhaegen F
    Phys Med Biol; 2005 Mar; 50(5):991-1000. PubMed ID: 15798271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic splitting of Gaussian pencil beams in heterogeneity-correction algorithms for radiotherapy with heavy charged particles.
    Kanematsu N; Komori M; Yonai S; Ishizaki A
    Phys Med Biol; 2009 Apr; 54(7):2015-27. PubMed ID: 19287085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chamber-quality factors in 60Co for three plane-parallel chambers for the dosimetry of electrons, protons and heavier charged particles: PENELOPE Monte Carlo simulations.
    Panettieri V; Sempau J; Andreo P
    Phys Med Biol; 2008 Nov; 53(21):5917-26. PubMed ID: 18836218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time imaging for dose evaluation during antiproton irradiation.
    Kantemiris I; Angelopoulos A; Bassler N; Giokaris N; Holzscheiter MH; Karaiskos P; Kalogeropoulos TE;
    Phys Med Biol; 2010 Mar; 55(5):N123-31. PubMed ID: 20134083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of stopping power ratios for carbon ion dosimetry.
    Geithner O; Andreo P; Sobolevsky N; Hartmann G; Jäkel O
    Phys Med Biol; 2006 May; 51(9):2279-92. PubMed ID: 16625042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET monitoring of cancer therapy with 3He and 12C beams: a study with the GEANT4 toolkit.
    Pshenichnov I; Larionov A; Mishustin I; Greiner W
    Phys Med Biol; 2007 Dec; 52(24):7295-312. PubMed ID: 18065840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analytical model for light ion pencil beam dose distributions: multiple scattering of primary and secondary ions.
    Hollmark M; Gudowska I; Belkić Dz; Brahme A; Sobolevsky N
    Phys Med Biol; 2008 Jul; 53(13):3477-91. PubMed ID: 18547916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
    Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
    Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the physical potential of proton beam range verification with PET/CT.
    Knopf A; Parodi K; Paganetti H; Cascio E; Bonab A; Bortfeld T
    Phys Med Biol; 2008 Aug; 53(15):4137-51. PubMed ID: 18635897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.